Trademark Overview
On Sunday, December 17, 2023, a trademark application was filed for PADIVAX with the United States Patent and Trademark Office. The USPTO has given the PADIVAX trademark a serial number of 98318085. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 22, 2024. This trademark is owned by POP Biotechnologies, Inc.. The PADIVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases
Vaccine research and development; Vaccine research and development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies
